a NR (Depakote 250 mg)

Generic Name: divalproex sodium

Pill imprint a NR has been identified as Depakote 250 mg.

Depakote is used in the treatment of bipolar disorder; mania; migraine prevention; epilepsy and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy and manic episodes associated with bipolar disorder: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Depakote 250 mg is not a controlled substance under the Controlled Substance Act (CSA).

Depakote

Generic Name:

divalproex sodium

Imprint:

a NR

Strength:

250 mg

Color:

Orange

Size:

15.00 mm

Shape:

Elliptical / Oval

Availability:

Prescription only

Drug Class:

Fatty acid derivative anticonvulsants

Pregnancy Category:

D - Positive evidence of risk - When treating epilepsy and manic episodes associated with bipolar disorder
X - Not for use in pregnancy - When treating migraine

CSA Schedule:

Not a controlled drug

Manufacturer:

Abbott Laboratories

National Drug Code (NDC):

00074-6214

Inactive Ingredients:

magnesium silicate
titanium dioxide
vanillin
FD&C Yellow No. 6
diacetylated monoglycerides
corn starch
povidone
silicon dioxide
FD&C Red No. 40

Other Manufacturers / Repackagers:

NDC Code	Manufacturer / Repackager
54868-1208	Physicians Total Care Inc (repackager)
55045-2484	Dispensing Solutions Inc. (repackager)
33358-0100	CorePharma, LLC (repackager)
16590-0587	Stat RX USA LLC (repackager)

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.